Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
General Information of Drug (ID: DR2496) | ||||||
---|---|---|---|---|---|---|
Drug Name |
HY-N0669
|
|||||
Synonyms |
Diterpene glycoside; Stevioside; Steviosin; UEDUENGHJMELGK-HYDKPPNVSA-N; ZINC245224268; (4alpha)-beta-D-Glucopyranosyl 13-((2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)kaur-16-en-18-oate; 0YON5MXJ9P; 13-[(2-O-.beta.-D-Glucopyranosyl-.alpha.-D-glucopyranosyl)oxy]kaur-16-en-18-oic acid .beta.-D-glucopyranosyl ester; 4-17-00-03618 (Beilstein Handbook Reference); 57817-89-7; AKOS015895872; C09189; CHEBI:9271; CHEMBL444122; CS-W019786; DS-6711; DTXSID7021281; HY-N0669; KS-00000H36; N1708; SCHEMBL33428; UNII-0YON5MXJ9P
|
|||||
Indication | Essential hypertension [ICD11: BA00] | Phase 2 | [1] | |||
Structure | ||||||
3D MOL is unavailable | 2D MOL | |||||
Pharmaceutical Properties | Molecular Weight | 804.9 | Topological Polar Surface Area | 295 | ||
Heavy Atom Count | 56 | Rotatable Bond Count | 10 | |||
Hydrogen Bond Donor Count | 11 | Hydrogen Bond Acceptor Count | 18 | |||
Cross-matching ID |
|
|||||
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.